I-Basaglar Insulin
-Delile
I-Basaglar insulin ikhonjisiwe ekwelashweni kwe- Isifo sikashukela thayipha 2 no Isifo sikashukela thayipha u-1 kubantu abadinga i-insulin yesikhathi eside ukulawula ushukela osegazini.
Lo ngumuthi we-biosimilar, njengoba uyikhophi eshibhile, kepha ngokusebenza nokuphepha okufanayo neLantus, okuwumuthi oyisithenjwa walokhu kwelashwa. Le insulin yenziwe yizinkampani U-Eli Lilly futhi I-Boehringer Ingelheim, sisonke, futhi sisanda kuvunywa i-ANVISA ngokuhweba eBrazil.
I-Basaglar insulin ingathengwa emakhemisi, ngentengo ecishe ibe yi-170 reais, lapho kwethulwa incwadi kadokotela.
Yenzelwe ini
I-Basaglar insulin ikhonjisiwe ekwelashweni kwe- Isifo sikashukela thayipha 2 no Isifo sikashukela thayipha i-1, kubantu abadala noma ezinganeni ezineminyaka engaphezu kwemibili, ezidinga isenzo se-insulin esebenza isikhathi eside ukulawula ushukela wegazi ngokweqile, futhi kufanele ukhonjiswe ngudokotela.
Lo muthi usebenza ngokwehlisa amazinga kashukela egazini egazini futhi uvumele i-glucose ukuthi isetshenziswe ngamaseli emzimbeni usuku lonke futhi ijwayele ukusetshenziswa nezinye izinhlobo ze-insulin esebenza ngokushesha noma ngama-antidiabetics omlomo. Qonda ukuthi yimaphi amakhambi asetshenziswa ukwelapha isifo sikashukela, nokuthi ukhonjiswa nini i-insulin.
Isetshenziswa kanjani
I-Basaglar insulin isetshenziswa ngemijovo efakwa kusikhumba esingaphansi kwesikhumba esiswini, ethangeni noma engalweni. Izicelo zenziwa kanye ngosuku, njalo ngasikhathi sinye, njengokuyalelwa ngudokotela.
Imiphumela emibi engaba khona
Eminye yemiphumela emibi kakhulu engabangelwa ukusetshenziswa kwe-Basaglar insulin yi-hypoglycemia, ukusabela okweqile, ukusabela endaweni yokujova, ukusatshalaliswa okungavamile kwamafutha emzimbeni, ukulunywa okujwayelekile, ukusabela kwesikhumba, ukuvuvukala nokuzuza kwesisindo.
Ngubani ongafanele asebenzise
I-Basaglar insulin iyaphikiswa kubantu abaguliswa yi-insulin glargine noma enye yezingxenye zefomula yomuthi.